Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Merck KGaA Mulls Sale of Pigments Unit -Bloomberg

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/20/2019 | 02:59am EST

--German pharmaceuticals and chemicals company Merck KGaA (MRK.XE) has met with potential bidders and financial advisers as it explores the sale of a pigments unit that could be valued at up to $1.7 billion, Bloomberg reports, citing sources.

--Germany's BASF and Switzerland's Clariant have both put their pigments operations on sale amid weaker demand in the automotive sector, Bloomberg reports.

Full story: https://bloom.bg/2XFbE77

Write to Barcelona editors at barcelonaeditors@dowjones.com

Stocks mentioned in the article
ChangeLast1st jan.
BASF SE 0.30% 67.55 Delayed Quote.11.51%
CLARIANT LTD 0.10% 20.67 Delayed Quote.14.15%
MERCK KGAA -0.44% 102.9 Delayed Quote.14.86%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERCK KGAA
12/10MERCK : EMD Serono and the pan-Canadian Pharmaceutical Alliance Complete Negotia..
AQ
12/10Merck, Sanofi Push To Add Cancer Drugs -- WSJ
DJ
12/09NEWS HIGHLIGHTS : Top Company News of the Day
DJ
12/09Health Care Down Amid Mixed Reactions To Cancer-Drug Acquisitions -- Health C..
DJ
12/09Wall Street falls as health shares drag
RE
12/09Big Drugmakers Push Deeper Into Cancer Treatment -- 3rd Update
DJ
12/09Big Drugmakers Push Deeper Into Cancer Treatment -- 2nd Update
DJ
12/09NEWS HIGHLIGHTS : Top Company News of the Day
DJ
11/26MERCK : Japan and Singapore Grant CRISPR Patents to MilliporeSigma
AQ
11/26Mass-Tort Machine Powers Wave of Roundup Lawsuits -2-
DJ
More news
Financials (EUR)
Sales 2019 16 039 M
EBIT 2019 2 247 M
Net income 2019 1 448 M
Debt 2019 9 482 M
Yield 2019 1,26%
P/E ratio 2019 31,1x
P/E ratio 2020 23,1x
EV / Sales2019 3,38x
EV / Sales2020 3,03x
Capitalization 44 739 M
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Average target price 107,92  €
Last Close Price 102,90  €
Spread / Highest target 29,4%
Spread / Average Target 4,88%
Spread / Lowest Target -17,4%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Member-Supervisory Board
Michael Fletterich Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA14.86%49 855
KYOWA KIRIN CO., LTD.18.11%11 844
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD15.86%8 510
JAZZ PHARMACEUTICALS PLC21.06%8 489
BETTA PHARMACEUTICALS CO LTD--.--%3 968
YUHAN CORP--.--%2 201